Information
-
Trademark
-
97382032
-
International Classifications
-
Filing Date
April 26, 2022
2 years ago
-
Transaction Date
December 14, 2023
6 months ago
-
Status Date
December 14, 2023
6 months ago
-
Location Date
December 14, 2023
6 months ago
-
Status Code
654
-
Current Location
TMO LAW OFFICE 120 - EXAMINING ATTORNEY ASSIGNED
Employee Name
GRYGIEL, JONATHAN C
-
Attorney Docket Number
S-16
Attorney Name
Scott B. Dunbar
Law Office Assigned Location Code
N20
-
Owners
Mark Drawing Code
4000
Mark Identification
NANOPORTAL
Case File Statements
- GS0051: Implantable drug delivery devices injected through a small needle having a drug reservoir filled with pharmaceutical preparations and a nanoporous membrane for improving medication adherence in the treatment of chronic diseases including, for example, metabolic diseases such as diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases such as Alzheimer's, dementia, sociopathy or psychopathy
- GS0011: Nanoporous membranes used in drug delivery devices injected through a small needle for controlling the rate of release of the subject therapeutic compound by selecting nano-pores slightly larger than the molecular diameter of the therapeutic compound; nanoporous membranes used for controlling the rate of release of the subject therapeutic compound by selecting nano-pores slightly larger than the molecular diameter of the therapeutic compound that control the amount and rate of drug released from a drug implant injected through a small needle where the drug reservoir dictates the duration of therapy delivered from the drug implant
- GS0101: Implantable drug delivery devices injected through a small needle having a drug reservoir and a nanoporous membrane; Nanoporous membranes used in drug delivery devices injected through a small needle for improving medication adherence in the treatment of chronic diseases including, for example, metabolic diseases such as diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases such as Alzheimer's, dementia, sociopathy or psychopathy; miniature long-term drug implants utilizing proprietary implantable drug delivery technology; nanoporous membranes used for improving medication adherence in the treatment of chronic diseases including, for example, metabolic diseases such as diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases such as Alzheimer's, dementia, sociopathy or psychopathy that control the amount and rate of drug released from a drug implant injected through a small needle where the drug reservoir dictates the duration of therapy delivered from the drug implant for treatment of metabolic diseases such as diabetes, obesity or non-alcoholic steatohepatits, and psychological diseases such as Alzheimer's, dementia, sociopathy or psychopathy, and other diseases treated with small drug molecules
Case File Event Statements
-
12/14/2023 - 6 months ago
13 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Type: RCSC
-
5/30/2023 - a year ago
12 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Type: GNS3
-
5/30/2023 - a year ago
11 - LETTER OF SUSPENSION E-MAILED
Type: GNSL
-
5/30/2023 - a year ago
10 - SUSPENSION LETTER WRITTEN
Type: CNSL
-
5/13/2023 - a year ago
9 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
5/12/2023 - a year ago
8 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
5/12/2023 - a year ago
7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
2/15/2023 - a year ago
6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
2/15/2023 - a year ago
5 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
2/15/2023 - a year ago
4 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
2/13/2023 - a year ago
3 - ASSIGNED TO EXAMINER
Type: DOCK
-
5/2/2022 - 2 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
4/29/2022 - 2 years ago
1 - NEW APPLICATION ENTERED
Type: NWAP